Blood-Derived Liquid Biopsies Using Foundation One(®) Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience

SIMPLE SUMMARY: Precision oncology requires tumor molecular profiling to identify actionable targets. Blood-derived liquid biopsy (LB) is a potential alternative that is not yet documented in real-world settings, especially in pediatric oncology. Analyzing, retrospectively, the use of LB in children...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahn, Fanny, Revon-Riviere, Gabriel, Min, Victoria, Rome, Angélique, Filaine, Pauline, Pelletier, Annick, Abed, Sylvie, Gentet, Jean-Claude, Verschuur, Arnauld, André, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179410/
https://www.ncbi.nlm.nih.gov/pubmed/35681754
http://dx.doi.org/10.3390/cancers14112774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179410/
https://www.ncbi.nlm.nih.gov/pubmed/35681754
http://dx.doi.org/10.3390/cancers14112774

Ejemplares similares